Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. : 3446-3462

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation

By  

Current Medicinal Chemistry, Vol. 13, Iss. 22, 2006-09 ,pp. : 2669-2680

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue-Specific Glucocorticoid Reactivating Enzyme, 11#946;-Hydroxysteoid Dehydrogenase Type 1 (11#946;-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite

Traditional Chinese Medicine in Treatment of Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 2, 2008-06 ,pp. : 99-111

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 895-903

Bentham Science Publishers

Access to resources Recommend Favorite